Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP272264.RAsV96gEKz8w6EmMcUMJ9EkJf-LvxppmXlzhyrysAbzLo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP272264.RAsV96gEKz8w6EmMcUMJ9EkJf-LvxppmXlzhyrysAbzLo130_assertion type Assertion NP272264.RAsV96gEKz8w6EmMcUMJ9EkJf-LvxppmXlzhyrysAbzLo130_head.
- NP272264.RAsV96gEKz8w6EmMcUMJ9EkJf-LvxppmXlzhyrysAbzLo130_assertion description "[Both BRAF and FBXW7 mutations functionally activate kinase effectors important in pancreatic cancer and extend the potential options for therapeutic targeting of kinases in the treatment of phenotypically distinct pancreatic adenocarcinoma subsets.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP272264.RAsV96gEKz8w6EmMcUMJ9EkJf-LvxppmXlzhyrysAbzLo130_provenance.
- NP272264.RAsV96gEKz8w6EmMcUMJ9EkJf-LvxppmXlzhyrysAbzLo130_assertion evidence source_evidence_literature NP272264.RAsV96gEKz8w6EmMcUMJ9EkJf-LvxppmXlzhyrysAbzLo130_provenance.
- NP272264.RAsV96gEKz8w6EmMcUMJ9EkJf-LvxppmXlzhyrysAbzLo130_assertion SIO_000772 14507635 NP272264.RAsV96gEKz8w6EmMcUMJ9EkJf-LvxppmXlzhyrysAbzLo130_provenance.
- NP272264.RAsV96gEKz8w6EmMcUMJ9EkJf-LvxppmXlzhyrysAbzLo130_assertion wasDerivedFrom befree-20150227 NP272264.RAsV96gEKz8w6EmMcUMJ9EkJf-LvxppmXlzhyrysAbzLo130_provenance.
- NP272264.RAsV96gEKz8w6EmMcUMJ9EkJf-LvxppmXlzhyrysAbzLo130_assertion wasGeneratedBy ECO_0000203 NP272264.RAsV96gEKz8w6EmMcUMJ9EkJf-LvxppmXlzhyrysAbzLo130_provenance.